MarketPeel
Insider Trading Intelligence
BB

Biotech Ag Bb

ESPR
10% OWNER · ESPERION THERAPEUTICS, INC. · CIK 0000924223
FILING MIX · LIFETIME85%/15%
BUYS
40
SELLS
7
TOTAL VALUE
$87.13M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
17,141,474
AVG SELL PX
$2.07
TRADE KIND
SHOWING 47 / 47
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
47 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Biotech Ag Bb, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d47+61.70%+3.15%+0.34%+2.81%-0.81%1.38
14d47+65.96%+4.53%-0.25%+4.78%+2.03%1.57
30d47+59.57%+1.27%+0.29%+0.97%-4.93%0.26
60d47+34.04%+0.04%+0.91%-0.87%-2.27%-0.24
90d47+48.94%+17.98%+2.91%+15.07%+23.96%2.75
180d47+25.53%+8.12%+7.87%+0.25%-21.37%0.02
1y47+27.66%-12.24%+9.54%-21.78%-32.21%-2.73
2y47(7 pending)+35.00%-14.04%+33.67%-47.71%-78.69%-4.51
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ESPR · 4,477,964 shares · as of May 24, 2021
01,119,4912,238,9823,358,4734,477,9642021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
FLOW · 40 buys / 7 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
584,292$1.95$1.14M3,233,547Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
1,000,000$2.07$2.07M7,517,839Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
300,000$1.94$582.9K7,217,839Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
1,000,000$2.31$2.31M6,217,839Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
400,000$2.09$837.2K3,817,839Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
2,000,000$2.00$4.00M4,217,839Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
SALE
500,000$2.12$1.06M2,733,547Mar 19, 2025Mar 20, 2025View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
400,000$2.34$934.1K8,517,839Oct 17, 2023Oct 19, 2023View →
MGNX
MACROGENICS INC
PURCHASE
150,000$4.46$669.6K9,929,963Oct 2, 2023Oct 4, 2023View →
MGNX
MACROGENICS INC
PURCHASE
200,000$5.26$1.05M9,779,963Sep 7, 2023Sep 11, 2023View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
1,000,000$5.00$5.00M8,117,839Jun 30, 2023Jul 3, 2023View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
1,740,000$5.49$9.56M7,117,839Jun 27, 2023Jun 29, 2023View →
MGNX
MACROGENICS INC
PURCHASE
500,000$5.07$2.53M9,579,963Feb 14, 2023Feb 16, 2023View →
MGNX
MACROGENICS INC
PURCHASE
150,000$5.30$794.9K9,079,963Jan 19, 2023Jan 23, 2023View →
MGNX
MACROGENICS INC
PURCHASE
200,000$5.61$1.12M8,929,963Dec 27, 2022Dec 28, 2022View →
MGNX
MACROGENICS INC
PURCHASE
200,000$5.88$1.18M8,729,963Dec 23, 2022Dec 28, 2022View →
MGNX
MACROGENICS INC
PURCHASE
300,000$5.96$1.79M8,529,963Nov 22, 2022Nov 24, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
99,801$2.25$224.9K5,377,839Oct 31, 2022Nov 2, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
172,974$2.18$377.0K5,278,038Oct 28, 2022Oct 31, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
191,678$1.87$359.2K5,105,064Oct 27, 2022Oct 31, 2022View →
MGNX
MACROGENICS INC
PURCHASE
250,000$4.36$1.09M8,229,963Oct 24, 2022Oct 25, 2022View →
MGNX
MACROGENICS INC
PURCHASE
250,000$4.63$1.16M7,979,963Oct 21, 2022Oct 25, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
87,850$1.51$132.8K4,913,386Oct 21, 2022Oct 25, 2022View →
MGNX
MACROGENICS INC
PURCHASE
285,977$4.00$1.14M7,729,963Oct 20, 2022Oct 21, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
53,734$1.42$76.3K4,825,536Oct 20, 2022Oct 21, 2022View →
MGNX
MACROGENICS INC
PURCHASE
168,422$3.70$623.9K7,443,986Oct 19, 2022Oct 21, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
77,689$1.32$102.8K4,771,802Oct 19, 2022Oct 21, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
255,711$2.57$657.9K4,694,113Apr 28, 2022Apr 29, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
150,000$2.66$399.5K4,438,402Apr 27, 2022Apr 29, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
150,000$3.24$486.6K4,288,402Apr 19, 2022Apr 20, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
150,000$3.29$493.9K4,138,402Apr 18, 2022Apr 20, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
102,556$3.57$366.2K3,988,402Apr 13, 2022Apr 13, 2022View →
BDTX
BLACK DIAMOND THERAPEUTICS, INC.
PURCHASE
150,000$3.42$513.6K3,885,846Apr 12, 2022Apr 13, 2022View →
MGNX
MACROGENICS INC
PURCHASE
200,000$18.50$3.70M7,275,564Nov 19, 2021Nov 23, 2021View →
MGNX
MACROGENICS INC
PURCHASE
100,000$20.47$2.05M7,075,564Sep 29, 2021Sep 30, 2021View →
MGNX
MACROGENICS INC
PURCHASE
100,000$20.64$2.06M6,975,564Sep 28, 2021Sep 30, 2021View →
MGNX
MACROGENICS INC
PURCHASE
200,000$19.93$3.99M6,875,564Sep 17, 2021Sep 20, 2021View →
MGNX
MACROGENICS INC
PURCHASE
400,000$20.94$8.38M6,675,564Sep 16, 2021Sep 20, 2021View →
MGNX
MACROGENICS INC
PURCHASE
75,000$21.74$1.63M6,275,564Jun 21, 2021Jun 23, 2021View →
MGNX
MACROGENICS INC
PURCHASE
100,000$21.04$2.10M6,200,564Jun 16, 2021Jun 17, 2021View →
MGNX
MACROGENICS INC
PURCHASE
75,000$20.53$1.54M6,100,564Jun 15, 2021Jun 17, 2021View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
100,000$20.22$2.02M4,477,964May 24, 2021May 26, 2021View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
200,000$20.37$4.07M4,377,964May 19, 2021May 21, 2021View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
80,000$20.57$1.65M4,177,964May 6, 2021May 7, 2021View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
150,000$20.02$3.00M4,097,964May 5, 2021May 7, 2021View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
200,000$25.31$5.06M3,947,964Nov 3, 2020Nov 4, 2020View →
ESPR
ESPERION THERAPEUTICS, INC.
PURCHASE
20,000$52.12$1.04M3,747,964Jan 23, 2020Jan 24, 2020View →
Other insiders · ESPR
Loading peer insiders…
About this filer
CIK 0000924223
ROLE
10% Owner
PRIMARY
ESPR
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0000924223DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback